Feisee Global Ip Challenges Washington Campus 2010

Intellectual Property Rights and Regulations in a Global Economy Lila Feisee Managing Director for Intellectual Property BIO January 6, 2010 Washington Campus

About BIO ,[object Object],[object Object],[object Object],[object Object],[object Object]

Today’s Topics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Role of biotech in the Economy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

The role of Biotech in the economy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Patents and Biotech ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Diligence Categories for Investors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pillars of Biotechnology’s Growth ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Basic Research Invention & Patent Filing 0 12 20 Marketing Approval Applied Research (including clinical work to obtain approval) Market Exclusivity Period Patent Expiration - 6 Fed $$$ Timeline for biotech therapeutic Development

Industry Use of Patents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],Global Innovation

46,576 total licenses/options executed from 1996 – 2006 **based on AUTM data

Challenges and Opportunities Patent and PTO reform

Challenges and Opportunities on the IP front ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Challenges and opportunities: In the Courts ,[object Object],[object Object],[object Object]

Is Reform Necessary? ,[object Object],[object Object],[object Object]

Challenges and Opportunities Healthcare Reform

Biosimilars Legislation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

FOBs Provisions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object]

Patent Provisions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Gene Patents and Federally funded Inventions ,[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Challenges and Opportunities Global IP

International IP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Patents are the Solution not the Problem ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Feisee Global Ip Challenges Washington Campus 2010

Recomendados

Recomendados

Más contenido relacionado

Similar a Feisee Global Ip Challenges Washington Campus 2010

Similar a Feisee Global Ip Challenges Washington Campus 2010 (20)

Feisee Global Ip Challenges Washington Campus 2010